Hipertansiyon Hastalarında Sağlık Kaderciliğinin Tedaviye Uyuma Etkisi

Year 2023, Volume: 5 Issue: 1, 29 - 36, 20.04.2023

Zülfünaz Özer , Gülcan Bahçecioğlu Turan

https://doi.org/10.48071/sbuhemsirelik.1217272

Abstract

Giriş: Hipertansiyon, yüksek prevalansı ve artmış kardiyovasküler hastalık riskiyle ilişkisi nedeniyle tüm dünyada en önemli sağlık sorunlarından biridir. Çevresel, fizyolojik ve psikolojik faktörler bu hastalığın tedavisinde etkili olabilmektedir.
Amaç: Bu araştırma hipertansiyon hastalarında sağlık kaderciliğinin tedaviye uyumlarına etkisinin incelemesi amacıyla yapıldı.
Yöntem: Tanımlayıcı ilişki arayıcı türde olan bu araştırma bir üniversite hastanesinin Dahili polikliniklerine başvuran 201 hipertansiyon hastası ile yapıldı. Veriler, Tanıtıcı Bilgi Formu, Dini Sağlığı Kadercilik Ölçeği ve Hill Bone Hipertansiyon Tedavisine Uyum Ölçeği kullanarak toplandı.
Bulgular: Hastaların Dini Sağlığı Kadercilik Ölçeği puan ortalaması 61,11 ± 13,30’dur. Hill Bone Hipertansiyon Tedavisine Uyum Ölçeği puanı 11,19 ± 6,62 olarak saptandı. Hastaların çalışma durumunun pozitif yönde, sağlık kontrolü yaptırma sıklığı ve ek kronik hastalık bulunma durumlarının ise negatif yönde din sağlığı kaderciliğini istatistiksel olarak etkilediği görüldü (p < 0,05). Hastaların çalışma durumlarının negatif yönde, ilaç sayısı ve ek kronik hastalık bulunma durumlarının ise pozitif yönde tedaviye uyumlarını istatistiksel olarak etkilediği belirlendi (p < 0,05). Dini Sağlığı Kadercilik Ölçeği’nin Hill Bone Hipertansiyon Tedavisine Uyum Ölçeği’ni negatif yönde etkilediği bulundu (p < 0,05).
Sonuç: Hipertansiyon hastalarının din sağlığı kaderciliği eğilimlerinin yüksek, tedaviye uyumlarının orta düzeyde olduğu saptandı. Din sağlığı kaderciliğinin tedaviye uyumlarını etkilediği bulundu.

Keywords

Hastalar, hipertansiyon, sağlık, tedavi uyumu

The Effects of Health Fatalism on Compliance to Treatment in Patients with Hypertension

Abstract

Introduction: Hypertension is one of the most important health problems all over the world due to its high prevalence and increased risk of cardiovascular disease. Environmental, physiological, and psychological factors can be effective in the treatment of this disease.
Aim: The present study was conducted to examine the effects of health fatalism on compliance to treatment in patients with hypertension.
Method: This descriptive and correlational study was conducted on 201 patients with hypertension admitted to the internal medicine outpatient clinics of a university hospital. The data were collected by using
Descriptive Information Form, Religious Health Fatalism Scale and Hill-Bone Compliance to High Blood Pressure Therapy Scale.
Results: Religious Health Fatalism Scale mean score of the patients was found as 61.11 ± 13.30. Hill-Bone Compliance to High Blood Pressure Therapy Scale mean score was seen as 11.19 ± 6.62. Employment status of the patients affected religious health fatalism statistically positively, while health check-up frequency and
having a comorbid chronic disease affected religious health fatalism statistically negatively (p < 0.05). Employment status of the patients affected compliance to treatment statistically negatively, while the number of drugs and having a comorbid chronic disease affected compliance to treatment statistically positively (p < 0.05). Religious Health Fatalism Scale affected Hill-Bone Compliance to High Blood Pressure Therapy Scale negatively (p < 0.05).
Conclusion: It was found that patients with hypertension had high level of religious health fatalism tendencies and moderate level of compliance to treatment. It was observed that religious health fatalism affected compliance to treatment.

Keywords

Health, hypertension, medication compliance, patients

References

• Abdul Rahman, A. R., Reyes, E.B., Sritara, P., Pancholia, A., Phuoc, D.V., & Tomlinson, B. (2015). Combination therapy in hypertension: an Asia-Pacific consensus viewpoint. Current Medical Research and Opinion, 31(5), 865-874.
• Afsahi, F., & Kachooei, M. (2020). Relationship between hypertension with irrational health beliefs and health locus of control. Journal of Education and Health Promotion, 9(100), 1-9
• Al-Daken, L.I., & Eshah, N.F. (2017). Self-reported adherence to therapeutic regimens among patients with hypertension. Clinical and Experimental Hypertension, 39(3), 264-270.
• Al-Hajje, A., Awada, S., Rachidi, S., Zein, S., Bawab, W., El-Hajj, Z., ... Salameh, P. (2015). Factors affecting medication adherence in Lebanese patients with chronic diseases. Pharmacy Practice, 13(3),590.
• Al-Ramahi, R. (2015). Adherence to medications and associated factors: A cross-sectional study among Palestinian hypertensive patients. Journal Epidemiol Global Health, 5(2), 125-132.
• Algabbani, F. M., & Algabbani, A. M. (2020). Treatment adherence among patients with hypertension: Findings from a cross-sectional study. Clinical Hypertension, 26(1), 1-9.
• Bobov, G., & Capik, C. (2020). The reliability and validity of the religious health fatalism scale in Turkish language. Journal of Religion and Health, 59(2), 1080-1095.
• Boztilki, M., ve Ardıç, E. (2017). Maneviyat ve sağlık. Journal of Academic Research in Nursing, 3(1), 39-45.
• Bramley, T. J., Nightengale, B. S., Frech-Tamas, F., & Gerbino, P. P. (2006). Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. Journal of Managed Care Pharmacy, 12(3), 239-245.
• Cingil, D., Delen, S., ve Aksuoğlu, A. (2009). Karaman il merkezinde yaşayan hipertansiyon hastalarının ilaç kullanım durumlarının ve bilgilerinin incelenmesi. Türk Kardiyoloji Derneği Arşivi, 37(8), 551-556.
• Cohn, L., & Esparza del Villar, O. (2015). Fatalism and health behavior: A meta-analytic review. Ciudad Juárez, México: Universidad Autónoma de Ciudad Juárez. Recuperado de https://bit. ly/2sAF5Iw.
• Conn, V. S., Ruppar, T. M., Chase, J.-A. D., Enriquez, M., & Cooper, P. S. (2015). Interventions to improve medication adherence in hypertensive patients: Systematic review and meta-analysis. Current Hypertension Reports, 17(12), 1-15.
• Çarkoğlu, A., ve Kalaycıoğlu, E. (2009). Türkiye’de Dindarlık: Uluslararası Bir Karşılaştırma. Erişim adresi (22.09.2022): https://research. sabanciuniv. edu/id/ eprint/14014/ 1/Rapor_ Dindar l %C4%B1k.pdf
• Dayapoglu, N., Ayyıldız, N. İ., & Şeker, D. (2021). Determination of health fatalism and the factors affecting health fatalism in patients with epilepsy in the North of Turkey. Epilepsy & Behavior, 115, 107641. https://doi.org/10.1016/j.yebeh.2020.107641
• Düsing, R. (2010). Optimizing blood pressure control through the use of fixed combinations. Vascular Health and Risk Management, 6, 321.
• Espinosa de los Monteros, K., & Gallo, L. C. (2013). Fatalism and cardio-metabolic dysfunction in Mexican–American women. International Journal of Behavioral Medicine, 20(4), 487-494.
• Franklin, M.D., Schlundt, D.G., McClellan, L.H., Kinebrew, T., Sheats, J., Belue, R., . . . Hargreaves, M. (2007). Religious fatalism and its association with health behaviors and outcomes. American Journal of Health Behavior, 31(6), 563-572.
• Franklin, M.D., Schlundt, D.G., & Wallston, K.A. (2008). Development and validation of a religious health fatalism measure for the African-American faith community. Journal of Health Psychology, 13(3), 323-335.
• Gee, M.E., Campbell, N.R., Gwadry-Sridhar, F., Nolan, R.P., Kaczorowski, J., Bienek, A., . . . Walker, R.L. (2012). Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Canadian Journal of Cardiology, 28(3), 383-389.
• Gozum, S., & Hacihasanoglu, R. (2009). Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients. European Journal of Cardiovascular Nursing, 8(2), 129-136.
• Gutierrez, A.P., McCurley, J. L., Roesch, S. C., Gonzalez, P., Castaneda, S. F., Penedo, F. J., & Gallo, L.C. (2017). Fatalism and hypertension prevalence, awareness, treatment and control in US Hispanics/Latinos: results from HCHS/SOL Sociocultural Ancillary Study. Journal of Behavioral Medicine, 40(2), 271-280.
• Gürdoğan, M., ve Gürdoğan, E.P. (2019). Hipertansiyon hastalarında tedaviye uyum ve ilişkili faktörler. MN Kardiyoloji, 26(3), 147-153.
• Karadağ, E., Akkuş, Y., ve Karatay, G. (2012). Bir aile sağlığı merkezine başvuran hipertansiyon hastalarının ilaç tedavisine uyum öz etkililik düzeyleri. . Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 28(3), 85-96.
• Karademir, M., Koseoglu, I. H., Vatansever, K., & Van Den Akker, M. (2009). Validity and reliability of the Turkish version of the Hill–Bone compliance to high blood pressure therapy scale for use in primary health care settings. The European Journal of General Practice, 15(4), 207-211.
• Kim, M.T., Hill, M.N., Bone, L.R., & Levine, D.M. (2000). Development and testing of the hill-bone compliance to high blood pressure therapy scale. Progress in Cardiovascular Nursing, 15(3), 90-96.
• Köten, E. (2021). Kadercilik, Sağlık Davranışı ve Covid-19: Bir Literatür İncelemesi. Sosyal Bilimler Araştırma Dergisi, 10(2), 515-528.
• Kretchy, I., Owusu-Daaku, F., & Danquah, S. (2013). Spiritual and religious beliefs: do they matter in the medication adherence behaviour of hypertensive patients? BioPsychoSocial Medicine, 7(1), 1-7.
• Kumar, N. (2019). To improve medication adherence in hypertensive patients. Journal of Advanced Medical and Dental Sciences Research, 7(9),262-266.
• Osamor, P. E., & Owumi, B. E. (2011). Factors associated with treatment compliance in hypertension in southwest Nigeria. Journal of Health, Population, And Nutrition, 29(6), 619.
• Özen, Y., & Rittersberger-Tılıç, H. (2018). Differences in the perception of health among the urban poor living in two squatter house neighbourhoods in Ankara. Akdeniz İnsani Bilimler Dergisi, 8(1), 309-333.
• Pan, J., Wu, L., Wang, H., Lei, T., Hu, B., Xue, X., & Li, Q. (2019). Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine, 98(27),1-7.
• Pehlivan, I., & Aktas, B. (2022). Relationship between medication compliance and fatalistic tendency in patients with hypertension. International Journal of Caring Sciences, 15(1), 167-177
• Ruiu, G. (2013). The origin of fatalistic tendencies: An empirical investigation. Economics & Sociology, 6(2), 103-125.
• Shahin, W., Kennedy, G. A., & Stupans, I. (2019). The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: A systematic review. Patient Preference and Adherence, 13, 1019-1035
• Spencer, J., Phillips, E., & Ogedegbe, G. (2005). Knowledge, attitudes, beliefs, and blood pressure control in a community-based sample in Ghana. Ethnicity and Disease, 15(4), 748.
• Şenuzun, F., Özer, S. (2012). Hipertansiyon ve Bakım. Z. Durna (Ed.), Kronik Hastalıklarda Bakım içinde (s. 96-97). İstanbul: İstanbul Nobel Matbaacılık.
• Tümer, A., Dereli, F., ve Demir Uysal, D. (2016). Hipertansiyon hastalarının ilaç tedavisine uyum düzeyleri. Turkish Journal of Cardiovascular Nursing, 7, 105-113.
• Türk Kardiyoloji Derneği. (2019).Retrieved from (21.10.2022): https:// tkd.org.tr/duyuru/3583/turk-kardiyoloji-dernegi-20-milyon-hipertansiyon-hastasi
• World Health Organization (WHO). (2022). Hypertension. Retrieved from (21.10.2022). https://www.who.int/news-room/fact-sheets/ detail/hypertension
• Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., . . . Dominiczak, A. (2018). 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Pressure, 27(6), 314-340.
• Wong, M., Jiang, J., & Griffiths, S. (2010). Factors associated with antihypertensive drug compliance in 83 884 Chinese patients: a cohort study. Journal of Epidemiology & Community Health, 64(10), 895-901.
• World Health Organization (WHO). (2003). Adherence to long-term therapies: evidence for action: World Health Organization. Retrieved from (21.10.2022): https:// apps. who. int/ iris/ handle/ 10665/42682